BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16304925)

  • 1. Determining pain levels in patients treated with maggot debridement therapy.
    Steenvoorde P; Budding T; Oskam J
    J Wound Care; 2005 Nov; 14(10):485-8. PubMed ID: 16304925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
    Gilead L; Mumcuoglu KY; Ingber A
    J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain related to maggot debridement therapy.
    Mumcuoglu KY; Davidson E; Avidan A; Gilead L
    J Wound Care; 2012 Aug; 21(8):400, 402, 404-5. PubMed ID: 22885313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications for maggots in wound care.
    Mumcuoglu KY
    Am J Clin Dermatol; 2001; 2(4):219-27. PubMed ID: 11705249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
    Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
    J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maggot therapy for wound debridement: a randomized multicenter trial.
    Opletalová K; Blaizot X; Mourgeon B; Chêne Y; Creveuil C; Combemale P; Laplaud AL; Sohyer-Lebreuilly I; Dompmartin A
    Arch Dermatol; 2012 Apr; 148(4):432-8. PubMed ID: 22184720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
    Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
    Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of maggot debridement therapy in promoting wound angiogenesis in patients with diabetic foot ulcer].
    Wang TY; Chen YC; Wang W; Jiang D; Liu L; Yang H; Wang AP
    Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1040-1049. PubMed ID: 33238687
    [No Abstract]   [Full Text] [Related]  

  • 9. Maggot debridement therapy and complementary wound care: a case series from Nigeria.
    Yusuf MA; Ibrahim BM; Oyebanji AA; Abubakar F; Ibrahim M; Ibrahim Jalo R; Aminu A; Akbarzadeh K; Azam M; Sheshe AA; Ganiyu OO; Abubakar MK; Salisu WJ; Kordshouli RS; Adamu AY; Takalmawa H; Daneji I; Aliyu M; Ibrahim MG; Kabuga AI; Abdullahi AS; Abbas MA
    J Wound Care; 2022 Nov; 31(11):996-1005. PubMed ID: 36367805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of Maggot Debridement Therapy for Chronic Wounds: A Bibliographic Review.
    Moya-López J; Costela-Ruiz V; García-Recio E; Sherman RA; De Luna-Bertos E
    Adv Skin Wound Care; 2020 Oct; 33(10):515-525. PubMed ID: 32941225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maggot débridement therapy in outpatients.
    Sherman RA; Sherman J; Gilead L; Lipo M; Mumcuoglu KY
    Arch Phys Med Rehabil; 2001 Sep; 82(9):1226-9. PubMed ID: 11552195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of medical-grade maggots in facilitating healing of diabetic foot ulcers in Kano, northern Nigeria: a case series.
    Yusuf MA; Ibrahim BM; Abubakar F; Ibrahim M; Sheshe AA; Abubakar MK; Aji SA; Gbadamasi KA; Busayo JK; Sallau SB; Ridwan BA; Uloko AE; Gezawa ID; Ramalan M; Sidi K; Abdullahi S; Adamu KM; Bello N; Muhammad A; Mukhtar R; Aina D
    J Wound Care; 2024 Feb; 33(Sup2):S24-S30. PubMed ID: 38348863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maggot debridement therapy in chronic wound care.
    Chan DC; Fong DH; Leung JY; Patil NG; Leung GK
    Hong Kong Med J; 2007 Oct; 13(5):382-6. PubMed ID: 17914145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maggot debridement therapy in the treatment of chronic wounds in a military hospital setup in Turkey.
    Tanyuksel M; Araz E; Dundar K; Uzun G; Gumus T; Alten B; Saylam F; Taylan-Ozkan A; Mumcuoglu KY
    Dermatology; 2005; 210(2):115-8. PubMed ID: 15724093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective, quality improvement review of maggot debridement therapy outcomes in a foot and leg ulcer clinic.
    Campbell N; Campbell D
    Ostomy Wound Manage; 2014 Jul; 60(7):16-25. PubMed ID: 25019246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maggot debridement therapy to treat hard-to-heal diabetic foot ulcers: a single-centre study.
    Nair HK; Ahmad NW; Ismail AA; Alabed AAA; Zheming BO; Kaur G; Hassan H; Supaat NI
    J Wound Care; 2021 Dec; 30(Sup12):S30-S36. PubMed ID: 34882006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maggot debridement therapy for the treatment of diabetic foot ulcers: a meta-analysis.
    Tian X; Liang XM; Song GM; Zhao Y; Yang XL
    J Wound Care; 2013 Sep; 22(9):462-9. PubMed ID: 24005780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Perceptions and Experiences With Maggot Debridement Therapy for Managing Chronic Wounds.
    Babiarczyk B; Tobiczyk J
    J Wound Ostomy Continence Nurs; 2024 May-Jun 01; 51(3):180-184. PubMed ID: 38595216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presurgical maggot debridement of soft tissue wounds is associated with decreased rates of postoperative infection.
    Sherman RA; Shimoda KJ
    Clin Infect Dis; 2004 Oct; 39(7):1067-70. PubMed ID: 15472863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maggot debridement therapy promotes diabetic foot wound healing by up-regulating endothelial cell activity.
    Sun X; Chen J; Zhang J; Wang W; Sun J; Wang A
    J Diabetes Complications; 2016 Mar; 30(2):318-22. PubMed ID: 26782021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.